A clinical trial site network that brings research to participants.
Lightship executes studies in-clinic, at home, virtually, and through mobile research units — all under one coordinated team. The result is faster enrollment, stronger retention, and broader representation, without the complexity of managing multiple vendors.

Performance that matters.

The Lightship model produces measurable, predictable results.
Over

2x

Enrollment rate

Sites offering home visits enroll participants at over twice the rate of traditional brick-and-mortar sites, because participation fits into patients’ lives.

As little as

6 weeks

For study startup

The expanded reach model activates studies about 40% faster than the industry average, so enrollment starts sooner.

Average

95%

PATIENT RETENTION
The expanded reach model removes the logistical barriers that drive dropout, keeping participants engaged through close-out.

.

40%+

DIVERSE REPRESENTATION
40%+ of the patients we engage come from racially or ethnically diverse communities, reflecting the populations trials are meant to serve.
MORE THAN

2.5x

GEOGRAPHIC REACH
The expanded reach model extends studies across more than 2.5x the geographic area of a traditional brick-and-mortar site.

The Lightship model.

Lightship executes studies across in-clinic, hybrid, virtual, and mobile research unit settings — matching each visit to what the protocol requires. From physical sites and multi-state investigator licensure, the network reaches participants across all 50 states.
.

Site Model

Site coverage allows for access to participants typically within ~30 miles of the site.
Best for protocols that require complex 
procedures, specialized equipment, or anchored in-person assessments.
Extends reach by 60%

Hybrid Model

Reduces travel burden with at-home and telemedicine touchpoints, typically extending geographic reach by 60%.
Best for protocols where some visits anchor in clinic and others move into the home or virtual settings.
.

Virtual Model

Allows for regional coverage, with visits 
conducted at home or 
via telemedicine and remote oversight 
from PIs/Sub-Is with multi-state licensure.
Best for protocols where every visit can safely occur outside a clinical setting.
Wave-Shape-Divider-Top-12

Mobile Research Units

MRUs bring research directly into communities, supporting 
prescreening, education, and select study visits where participants 
live and work, extending Lightship’s reach beyond the traditional site.

Why sponsors choose Lightship.

Four things shape every Lightship study, no matter the model or the setting.

One Trusted Partner

Adding flexibility to a trial usually means adding vendors: a separate nursing agency, a separate telemedicine platform, separate SOPs. Lightship replaces the vendor stack with one coordinated partner. Investigators, nurses, and coordinators all operate under the same framework — no matter where the visit happens.

Quality First

More than 30 sponsor audits completed with zero critical findings. Lightship has engaged the FDA twice and received supportive feedback on its hybrid and MRU-based delivery model. The same investigator, the same SOPs, and the same oversight standard apply whether the visit happens at a site in Texas or a participant’s living room in Massachusetts.

Technology Agnostic

The Lightship model is technology-agnostic. We can use our selected tech stack or integrate with the platforms and workflows sponsors already use — supporting trial teams within their existing systems.

Therapeutic Depth

Investigators with experience across 13 therapeutic areas. Multi-state licensure extends specialized care into communities traditional sites can’t reach.

Experience across a variety of therapeutic areas

Execute your next trial with Lightship.

Connect with our team to scope your study and explore the right model for your protocol.